{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:54:30Z","timestamp":1790628870199,"version":"4.1.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In the pharmaceutical manufacturing, drug release behavior development is remained as one of the main challenges to improve the drug effectiveness. Recently, more focus has been done on using mesoporous silica materials as drug carriers for prolonged and superior control of drug release in human body. In this study, release behavior of paracetamol is developed using drug-loaded KCC-1-NH<jats:sub>2<\/jats:sub> mesoporous silica, based on direct compaction method for preparation of tablets. The purpose of this study is to investigate the utilizing of pure KCC-1 mesoporous silica (KCC-1) and amino functionalized KCC-1 (KCC-1-NH<jats:sub>2<\/jats:sub>) as drug carriers in oral solid dosage formulations compared to common excipient, microcrystalline cellulose (MCC), to improve the control of drug release rate by manipulating surface chemistry of the carrier. Different formulations of KCC-1 and KCC-NH<jats:sub>2<\/jats:sub> are designed to investigate the effect of functionalized mesoporous silica as carrier on drug controlled-release rate. The results displayed the remarkable effect of KCC-1-NH<jats:sub>2<\/jats:sub> on drug controlled-release in comparison with the formulation containing pure KCC-1 and formulation including MCC as reference materials. The pure KCC-1 and KCC-1-NH<jats:sub>2<\/jats:sub> are characterized using different evaluation methods such as FTIR, SEM, TEM and N<jats:sub>2<\/jats:sub> adsorption analysis.<\/jats:p>","DOI":"10.1038\/s41598-020-79983-8","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T18:36:08Z","timestamp":1610476568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Controlled release evaluation of paracetamol loaded amine functionalized mesoporous silica KCC1 compared to microcrystalline cellulose based tablets"],"prefix":"10.1038","volume":"11","author":[{"given":"Marieh","family":"Pishnamazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Hafizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboubeh","family":"Pishnamazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Marjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Shirazian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin M.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"key":"79983_CR1","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1021\/la062450w","volume":"23","author":"JM Rosenholm","year":"2007","unstructured":"Rosenholm, J. M., Czuryszkiewicz, T., Kleitz, F., Rosenholm, J. B. & Lind\u00e9n, M. On the nature of the Br\u00f8nsted acidic groups on native and functionalized mesoporous siliceous SBA-15 as studied by benzylamine adsorption from solution. Langmuir 23, 4315\u20134323. https:\/\/doi.org\/10.1021\/la062450w (2007).","journal-title":"Langmuir"},{"key":"79983_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejps.2016.06.001","volume":"95","author":"E von Haartman","year":"2016","unstructured":"von Haartman, E., Lindberg, D., Prabhakar, N. & Rosenholm, J. M. On the intracellular release mechanism of hydrophobic cargo and its relation to the biodegradation behavior of mesoporous silica nanocarriers. Eur. J. Pharm. Sci. 95, 17\u201327. https:\/\/doi.org\/10.1016\/j.ejps.2016.06.001 (2016).","journal-title":"Eur. J. Pharm. Sci."},{"key":"79983_CR3","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.3390\/nano9101423","volume":"9","author":"KX Lee","year":"2019","unstructured":"Lee, K. X. et al. Bio-mediated synthesis and characterisation of silver nanocarrier, and its potent anticancer action. Nanomaterials (Basel) 9, 1423. https:\/\/doi.org\/10.3390\/nano9101423 (2019).","journal-title":"Nanomaterials (Basel)"},{"key":"79983_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijpharm.2018.07.037","volume":"549","author":"M S\u00f6nmez","year":"2018","unstructured":"S\u00f6nmez, M. et al. Applications of mesoporous silica in biosensing and controlled release of insulin. Int. J. Pharmaceut. 549, 179\u2013200. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.07.037 (2018).","journal-title":"Int. J. Pharmaceut."},{"key":"79983_CR5","doi-asserted-by":"publisher","first-page":"110115","DOI":"10.1016\/j.micromeso.2020.110115","volume":"299","author":"A Bakhshian Nik","year":"2020","unstructured":"Bakhshian Nik, A. et al. Smart drug delivery: Capping strategies for mesoporous silica nanoparticles. Microporous Mesoporous Mater. 299, 110115. https:\/\/doi.org\/10.1016\/j.micromeso.2020.110115 (2020).","journal-title":"Microporous Mesoporous Mater."},{"key":"79983_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.matlet.2014.06.026","volume":"131","author":"Y He","year":"2014","unstructured":"He, Y. et al. Fabrication of mesoporous spherical silica nanoparticles and effects of synthesis conditions on particle mesostructure. Mater. Lett. 131, 361\u2013365. https:\/\/doi.org\/10.1016\/j.matlet.2014.06.026 (2014).","journal-title":"Mater. Lett."},{"key":"79983_CR7","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.solidstatesciences.2006.04.016","volume":"8","author":"P Horcajada","year":"2006","unstructured":"Horcajada, P., R\u00e1mila, A., F\u00e9rey, G. & Vallet-Reg\u00ed, M. Influence of superficial organic modification of MCM-41 matrices on drug delivery rate. Solid State Sci. 8, 1243\u20131249. https:\/\/doi.org\/10.1016\/j.solidstatesciences.2006.04.016 (2006).","journal-title":"Solid State Sci."},{"key":"79983_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/cphc.200390045","volume":"4","author":"C Tourn\u00e9-P\u00e9teilh","year":"2003","unstructured":"Tourn\u00e9-P\u00e9teilh, C. et al. The potential of ordered mesoporous silica for the storage of drugs: The example of a pentapeptide encapsulated in a MSU-Tween 80. ChemPhysChem 4, 281\u2013286. https:\/\/doi.org\/10.1002\/cphc.200390045 (2003).","journal-title":"ChemPhysChem"},{"key":"79983_CR9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1021\/cm021217q","volume":"15","author":"B Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz, B., R\u00e1mila, A., P\u00e9rez-Pariente, J., D\u00edaz, I. & Vallet-Reg\u00ed, M. MCM-41 organic modification as drug delivery rate regulator. Chem. Mater. 15, 500\u2013503. https:\/\/doi.org\/10.1021\/cm021217q (2003).","journal-title":"Chem. Mater."},{"key":"79983_CR10","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1021\/ja028650l","volume":"125","author":"C-Y Lai","year":"2003","unstructured":"Lai, C.-Y. et al. A Mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J. Am. Chem. Soc. 125, 4451\u20134459. https:\/\/doi.org\/10.1021\/ja028650l (2003).","journal-title":"J. Am. Chem. Soc."},{"key":"79983_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.micromeso.2008.07.002","volume":"117","author":"S Wang","year":"2009","unstructured":"Wang, S. Ordered mesoporous materials for drug delivery. Microporous Mesoporous Mater. 117, 1\u20139. https:\/\/doi.org\/10.1016\/j.micromeso.2008.07.002 (2009).","journal-title":"Microporous Mesoporous Mater."},{"key":"79983_CR12","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1039\/C9TB02494H","volume":"8","author":"E-B Lim","year":"2020","unstructured":"Lim, E.-B., Vy, T. A. & Lee, S.-W. Comparative release kinetics of small drugs (ibuprofen and acetaminophen) from multifunctional mesoporous silica nanoparticles. J. Mater. Chem. B 8, 2096\u20132106. https:\/\/doi.org\/10.1039\/C9TB02494H (2020).","journal-title":"J. Mater. Chem. B"},{"key":"79983_CR13","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.talanta.2003.10.028","volume":"62","author":"PK Jal","year":"2004","unstructured":"Jal, P. K., Patel, S. & Mishra, B. K. Chemical modification of silica surface by immobilization of functional groups for extractive concentration of metal ions. Talanta 62, 1005\u20131028. https:\/\/doi.org\/10.1016\/j.talanta.2003.10.028 (2004).","journal-title":"Talanta"},{"key":"79983_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijpharm.2010.06.053","volume":"397","author":"CA Aerts","year":"2010","unstructured":"Aerts, C. A. et al. Potential of amorphous microporous silica for ibuprofen controlled release. Int. J. Pharmaceut. 397, 84\u201391. https:\/\/doi.org\/10.1016\/j.ijpharm.2010.06.053 (2010).","journal-title":"Int. J. Pharmaceut."},{"key":"79983_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.micromeso.2016.08.014","volume":"235","author":"ZS Eren","year":"2016","unstructured":"Eren, Z. S. et al. Improved solubility of celecoxib by inclusion in SBA-15 mesoporous silica: Drug loading in different solvents and release. Microporous Mesoporous Mater. 235, 211\u2013223. https:\/\/doi.org\/10.1016\/j.micromeso.2016.08.014 (2016).","journal-title":"Microporous Mesoporous Mater."},{"key":"79983_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.micromeso.2011.06.001","volume":"147","author":"Y Hu","year":"2012","unstructured":"Hu, Y. et al. 3D cubic mesoporous silica microsphere as a carrier for poorly soluble drug carvedilol. Microporous Mesoporous Mater. 147, 94\u2013101. https:\/\/doi.org\/10.1016\/j.micromeso.2011.06.001 (2012).","journal-title":"Microporous Mesoporous Mater."},{"key":"79983_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp200287c","volume":"9","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y. et al. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs. Mol. Pharm. 9, 505\u2013513. https:\/\/doi.org\/10.1021\/mp200287c (2012).","journal-title":"Mol. Pharm."},{"key":"79983_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.addr.2007.05.003","volume":"59","author":"F Kesisoglou","year":"2007","unstructured":"Kesisoglou, F., Panmai, S. & Wu, Y. Nanosizing\u2014oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev. 59, 631\u2013644. https:\/\/doi.org\/10.1016\/j.addr.2007.05.003 (2007).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"79983_CR19","doi-asserted-by":"publisher","first-page":"105103","DOI":"10.1016\/j.ejps.2019.105103","volume":"142","author":"AH Ibrahim","year":"2020","unstructured":"Ibrahim, A. H. et al. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin. Eur. J. Pharm. Sci. 142, 105103. https:\/\/doi.org\/10.1016\/j.ejps.2019.105103 (2020).","journal-title":"Eur. J. Pharm. Sci."},{"key":"79983_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ijpharm.2017.11.054","volume":"536","author":"J Riikonen","year":"2018","unstructured":"Riikonen, J., Xu, W. & Lehto, V.-P. Mesoporous systems for poorly soluble drugs\u2014recent trends. Int. J. Pharmaceut. 536, 178\u2013186. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.11.054 (2018).","journal-title":"Int. J. Pharmaceut."},{"key":"79983_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1517\/17425247.4.4.403","volume":"4","author":"A Fahr","year":"2007","unstructured":"Fahr, A. & Liu, X. Drug delivery strategies for poorly water-soluble drugs. Expert Opin. Drug Deliv. 4, 403\u2013416. https:\/\/doi.org\/10.1517\/17425247.4.4.403 (2007).","journal-title":"Expert Opin. Drug Deliv."},{"key":"79983_CR22","doi-asserted-by":"publisher","first-page":"9568","DOI":"10.1021\/la051167e","volume":"21","author":"SW Song","year":"2005","unstructured":"Song, S. W., Hidajat, K. & Kawi, S. Functionalized SBA-15 materials as carriers for controlled drug delivery: Influence of surface properties on matrix-drug interactions. Langmuir 21, 9568\u20139575. https:\/\/doi.org\/10.1021\/la051167e (2005).","journal-title":"Langmuir"},{"key":"79983_CR23","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.1016\/j.apsusc.2012.03.041","volume":"258","author":"Y Xu","year":"2012","unstructured":"Xu, Y., Wang, C., Zhou, G., Wu, Y. & Chen, J. Improving the controlled release of water-insoluble emodin from amino-functionalized mesoporous silica. Appl. Surf. Sci. 258, 6366\u20136372. https:\/\/doi.org\/10.1016\/j.apsusc.2012.03.041 (2012).","journal-title":"Appl. Surf. Sci."},{"key":"79983_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jconrel.2008.02.013","volume":"128","author":"JM Rosenholm","year":"2008","unstructured":"Rosenholm, J. M. & Lind\u00e9n, M. Towards establishing structure\u2013activity relationships for mesoporous silica in drug delivery applications. J. Control Release 128, 157\u2013164. https:\/\/doi.org\/10.1016\/j.jconrel.2008.02.013 (2008).","journal-title":"J. Control Release"},{"key":"79983_CR25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jcis.2014.08.019","volume":"434","author":"S Jambhrunkar","year":"2014","unstructured":"Jambhrunkar, S. et al. Modulating in vitro release and solubility of griseofulvin using functionalized mesoporous silica nanoparticles. J. Colloid Interface Sci. 434, 218\u2013225. https:\/\/doi.org\/10.1016\/j.jcis.2014.08.019 (2014).","journal-title":"J. Colloid Interface Sci."},{"key":"79983_CR26","doi-asserted-by":"publisher","first-page":"13534","DOI":"10.1021\/jacs.8b04843","volume":"140","author":"V Dubovoy","year":"2018","unstructured":"Dubovoy, V. et al. One-pot hydrothermal synthesis of benzalkonium-templated mesostructured silica antibacterial agents. J. Am. Chem. Soc. 140, 13534\u201313537. https:\/\/doi.org\/10.1021\/jacs.8b04843 (2018).","journal-title":"J. Am. Chem. Soc."},{"key":"79983_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ijpharm.2011.05.021","volume":"414","author":"P Kinnari","year":"2011","unstructured":"Kinnari, P. et al. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole. Int. J. Pharmaceut. 414, 148\u2013156. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.05.021 (2011).","journal-title":"Int. J. Pharmaceut."},{"key":"79983_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.msec.2013.12.006","volume":"36","author":"C Yang","year":"2014","unstructured":"Yang, C. et al. pH-responsive controlled-release system based on mesoporous bioglass materials capped with mineralized hydroxyapatite. Mater. Sci. Eng. C 36, 237\u2013243. https:\/\/doi.org\/10.1016\/j.msec.2013.12.006 (2014).","journal-title":"Mater. Sci. Eng. C"},{"key":"79983_CR29","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1002\/adma.200400771","volume":"16","author":"C Barb\u00e9","year":"2004","unstructured":"Barb\u00e9, C. et al. Silica particles: A novel drug-delivery system. Adv. Mater. 16, 1959\u20131966. https:\/\/doi.org\/10.1002\/adma.200400771 (2004).","journal-title":"Adv. Mater."},{"key":"79983_CR30","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1021\/cm0401490","volume":"16","author":"J Andersson","year":"2004","unstructured":"Andersson, J., Rosenholm, J., Areva, S. & Lind\u00e9n, M. Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matrices. Chem. Mater. 16, 4160\u20134167. https:\/\/doi.org\/10.1021\/cm0401490 (2004).","journal-title":"Chem. Mater."},{"key":"79983_CR31","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/j.jssc.2006.04.002","volume":"179","author":"F Qu","year":"2006","unstructured":"Qu, F. et al. A controlled release of ibuprofen by systematically tailoring the morphology of mesoporous silica materials. J. Solid State Chem. 179, 2027\u20132035. https:\/\/doi.org\/10.1016\/j.jssc.2006.04.002 (2006).","journal-title":"J. Solid State Chem."},{"key":"79983_CR32","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/adma.201104763","volume":"24","author":"F Tang","year":"2012","unstructured":"Tang, F., Li, L. & Chen, D. Mesoporous silica nanoparticles: Synthesis, biocompatibility and drug delivery. Adv. Mater. 24, 1504\u20131534. https:\/\/doi.org\/10.1002\/adma.201104763 (2012).","journal-title":"Adv. Mater."},{"key":"79983_CR33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ijpharm.2016.05.067","volume":"510","author":"H Geng","year":"2016","unstructured":"Geng, H. et al. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release. Int. J. Pharmaceut. 510, 184\u2013194. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.05.067 (2016).","journal-title":"Int. J. Pharmaceut."},{"key":"79983_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.micromeso.2017.08.037","volume":"257","author":"SM Sadeghzadeh","year":"2018","unstructured":"Sadeghzadeh, S. M., Zhiani, R., Khoobi, M. & Emrani, S. Synthesis of 3-acyloxylindolines under mild conditions using tripolyphosphate-grafted KCC-1-NH2. Microporous Mesoporous Mater. 257, 147\u2013153. https:\/\/doi.org\/10.1016\/j.micromeso.2017.08.037 (2018).","journal-title":"Microporous Mesoporous Mater."},{"key":"79983_CR35","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.biomaterials.2007.10.019","volume":"29","author":"P Yang","year":"2008","unstructured":"Yang, P., Quan, Z., Lu, L., Huang, S. & Lin, J. Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems. Biomaterials 29, 692\u2013702. https:\/\/doi.org\/10.1016\/j.biomaterials.2007.10.019 (2008).","journal-title":"Biomaterials"},{"key":"79983_CR36","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1002\/jps.22577","volume":"100","author":"T Limnell","year":"2011","unstructured":"Limnell, T. et al. Drug delivery formulations of ordered and nonordered mesoporous silica: Comparison of three drug loading methods. J. Pharm. Sci. 100, 3294\u20133306. https:\/\/doi.org\/10.1002\/jps.22577 (2011).","journal-title":"J. Pharm. Sci."},{"key":"79983_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1517\/17425247.2015.1111335","volume":"13","author":"A Maleki","year":"2016","unstructured":"Maleki, A. & Hamidi, M. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: Comparison of MSF with SBA-15 as drug carriers. Expert Opin. Drug Deliv. 13, 171\u2013181. https:\/\/doi.org\/10.1517\/17425247.2015.1111335 (2016).","journal-title":"Expert Opin. Drug Deliv."},{"key":"79983_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1179\/030801800679206","volume":"25","author":"SS Davis","year":"2000","unstructured":"Davis, S. S. Drug delivery systems. Interdiscip. Sci. Rev. 25, 175\u2013183. https:\/\/doi.org\/10.1179\/030801800679206 (2000).","journal-title":"Interdiscip. Sci. Rev."},{"key":"79983_CR39","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jconrel.2005.08.017","volume":"108","author":"J Salonen","year":"2005","unstructured":"Salonen, J. et al. Mesoporous silicon microparticles for oral drug delivery: Loading and release of five model drugs. J. Control Release 108, 362\u2013374. https:\/\/doi.org\/10.1016\/j.jconrel.2005.08.017 (2005).","journal-title":"J. Control Release"},{"key":"79983_CR40","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/03639045.2018.1542709","volume":"45","author":"KE Bremmell","year":"2019","unstructured":"Bremmell, K. E. & Prestidge, C. A. Enhancing oral bioavailability of poorly soluble drugs with mesoporous silica based systems: Opportunities and challenges. Drug Dev. Ind. Pharm. 45, 349\u2013358. https:\/\/doi.org\/10.1080\/03639045.2018.1542709 (2019).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"79983_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1517\/17425247.2016.1100165","volume":"13","author":"CA McCarthy","year":"2016","unstructured":"McCarthy, C. A., Ahern, R. J., Dontireddy, R., Ryan, K. B. & Crean, A. M. Mesoporous silica formulation strategies for drug dissolution enhancement: A review. Expert Opin. Drug Deliv. 13, 93\u2013108. https:\/\/doi.org\/10.1517\/17425247.2016.1100165 (2016).","journal-title":"Expert Opin. Drug Deliv."},{"key":"79983_CR42","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jconrel.2017.07.047","volume":"262","author":"A Maleki","year":"2017","unstructured":"Maleki, A. et al. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs. J. Control Release 262, 329\u2013347. https:\/\/doi.org\/10.1016\/j.jconrel.2017.07.047 (2017).","journal-title":"J. Control Release"},{"key":"79983_CR43","doi-asserted-by":"publisher","first-page":"18358","DOI":"10.1021\/jp3063959","volume":"116","author":"A Datt","year":"2012","unstructured":"Datt, A., El-Maazawi, I. & Larsen, S. C. Aspirin loading and release from MCM-41 functionalized with aminopropyl groups via co-condensation or postsynthesis modification methods. J. Phys. Chem. C 116, 18358\u201318366. https:\/\/doi.org\/10.1021\/jp3063959 (2012).","journal-title":"J. Phys. Chem. C"},{"key":"79983_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-59745-210-6_1","volume":"437","author":"K Jain","year":"2008","unstructured":"Jain, K. Drug delivery systems\u2014an overview. Methods Mol. Biol. (Clifton N.J.) 437, 1\u201350. https:\/\/doi.org\/10.1007\/978-1-59745-210-6_1 (2008).","journal-title":"Methods Mol. Biol. (Clifton N.J.)"},{"key":"79983_CR45","unstructured":"https:\/\/www.intechopen.com\/books\/advanced-technology-for-delivering-therapeutics\/introductory-chapter-drug-delivery-concepts. (2016)."},{"key":"79983_CR46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.etap.2014.07.001","volume":"38","author":"K Vijayakaran","year":"2014","unstructured":"Vijayakaran, K. et al. Arsenic decreases antinociceptive activity of paracetamol: Possible involvement of serotonergic and endocannabinoid receptors. Environ. Toxicol. Pharmacol. 38, 397\u2013405. https:\/\/doi.org\/10.1016\/j.etap.2014.07.001 (2014).","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"79983_CR47","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1081\/DDC-120016718","volume":"29","author":"S Miyazaki","year":"2003","unstructured":"Miyazaki, S. et al. Oral sustained delivery of paracetamol from in situ gelling xyloglucan formulations. Drug Dev. Ind. Pharm. 29, 113\u2013119. https:\/\/doi.org\/10.1081\/DDC-120016718 (2003).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"79983_CR48","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.3109\/21691401.2015.1042109","volume":"44","author":"E Bulut","year":"2016","unstructured":"Bulut, E. Controlled delivery of the popular nonsteroidal anti-inflammatory drug, paracetamol, from chitosan-g-polyacrylamide microspheres prepared by the emulsion crosslinking technique. Artif. Cells Nanomed. Biotechnol. 44, 1482\u20131490. https:\/\/doi.org\/10.3109\/21691401.2015.1042109 (2016).","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"79983_CR49","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/s0168-3659(03)00011-7","volume":"88","author":"M Grassi","year":"2003","unstructured":"Grassi, M. et al. Preparation and evaluation of a melt pelletised paracetamol\/stearic acid sustained release delivery system. J. Control Release 88, 381\u2013391. https:\/\/doi.org\/10.1016\/s0168-3659(03)00011-7 (2003).","journal-title":"J. Control Release"},{"key":"79983_CR50","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/02652040500100261","volume":"22","author":"MK Lai","year":"2005","unstructured":"Lai, M. K. & Tsiang, R. C. C. Microencapsulation of acetaminophen into poly(l-lactide) by three different emulsion solvent-evaporation methods. J. Microencapsul. 22, 261\u2013274. https:\/\/doi.org\/10.1080\/02652040500100261 (2005).","journal-title":"J. Microencapsul."},{"key":"79983_CR51","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ijpharm.2005.11.012","volume":"308","author":"AR Duarte","year":"2006","unstructured":"Duarte, A. R., Costa, M. S., Simpl\u00edcio, A. L., Cardoso, M. M. & Duarte, C. M. Preparation of controlled release microspheres using supercritical fluid technology for delivery of anti-inflammatory drugs. Int. J. Pharm. 308, 168\u2013174. https:\/\/doi.org\/10.1016\/j.ijpharm.2005.11.012 (2006).","journal-title":"Int. J. Pharm."},{"key":"79983_CR52","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4028\/www.scientific.net\/AMR.586.161","volume":"586","author":"HR Zhou","year":"2012","unstructured":"Zhou, H. R., Zhang, J. Y. & Jiang, H. The preparation and characteristics of chitosan-acetaminophen drug-loading micropheres. Adv. Mater. Res. 586, 161\u2013165. https:\/\/doi.org\/10.4028\/www.scientific.net\/AMR.586.161 (2012).","journal-title":"Adv. Mater. Res."},{"key":"79983_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0378-5173(94)00368-F","volume":"119","author":"J Fujimori","year":"1995","unstructured":"Fujimori, J., Machida, Y., Tanaka, S. & Nagai, T. Effect of magnetically controlled gastric residence of sustained release tablets on bioavailability of acetaminophen. Int. J. Pharmaceut. 119, 47\u201355. https:\/\/doi.org\/10.1016\/0378-5173(94)00368-F (1995).","journal-title":"Int. J. Pharmaceut."},{"key":"79983_CR54","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.jssc.2011.03.005","volume":"184","author":"A Szegedi","year":"2011","unstructured":"Szegedi, A., Popova, M., Goshev, I. & Mih\u00e1ly, J. Effect of amine functionalization of spherical MCM-41 and SBA-15 on controlled drug release. J. Solid State Chem. 184, 1201\u20131207. https:\/\/doi.org\/10.1016\/j.jssc.2011.03.005 (2011).","journal-title":"J. Solid State Chem."},{"key":"79983_CR55","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7439.1000360","author":"K AbouAitah","year":"2016","unstructured":"AbouAitah, K. & Farghali, A. Mesoporous silica materials in drug delivery system: pH\/glutathione-responsive release of poorly water-soluble pro-drug Quercetin from two and three-dimensional pore-structure nanoparticles. J. Nanomed. Nanotechnol. https:\/\/doi.org\/10.4172\/2157-7439.1000360 (2016).","journal-title":"J. Nanomed. Nanotechnol."},{"key":"79983_CR56","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jconrel.2010.04.029","volume":"145","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. et al. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan. J. Control Release 145, 257\u2013263. https:\/\/doi.org\/10.1016\/j.jconrel.2010.04.029 (2010).","journal-title":"J. Control Release"},{"key":"79983_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.micromeso.2005.12.004","volume":"92","author":"F Qu","year":"2006","unstructured":"Qu, F. et al. Controlled release of Captopril by regulating the pore size and morphology of ordered mesoporous silica. Microporous Mesoporous Mater. 92, 1\u20139. https:\/\/doi.org\/10.1016\/j.micromeso.2005.12.004 (2006).","journal-title":"Microporous Mesoporous Mater."},{"key":"79983_CR58","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.micromeso.2003.12.012","volume":"68","author":"P Horcajada","year":"2004","unstructured":"Horcajada, P. et al. Influence of pore size of MCM-41 matrices on drug delivery rate. Microporous Mesoporous Mater. 68, 105\u2013109. https:\/\/doi.org\/10.1016\/j.micromeso.2003.12.012 (2004).","journal-title":"Microporous Mesoporous Mater."},{"key":"79983_CR59","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ejpb.2007.11.006","volume":"69","author":"R Mellaerts","year":"2008","unstructured":"Mellaerts, R. et al. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica. Eur. J. Pharm. Biopharm. 69, 223\u2013230. https:\/\/doi.org\/10.1016\/j.ejpb.2007.11.006 (2008).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"79983_CR60","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijpharm.2006.09.019","volume":"331","author":"T Heikkil\u00e4","year":"2007","unstructured":"Heikkil\u00e4, T. et al. Mesoporous silica material TUD-1 as a drug delivery system. Int. J. Pharmaceut. 331, 133\u2013138. https:\/\/doi.org\/10.1016\/j.ijpharm.2006.09.019 (2007).","journal-title":"Int. J. Pharmaceut."},{"key":"79983_CR61","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.micromeso.2016.04.029","volume":"229","author":"MM Ayad","year":"2016","unstructured":"Ayad, M. M., Salahuddin, N. A., El-Nasr, A. A. & Torad, N. L. Amine-functionalized mesoporous silica KIT-6 as a controlled release drug delivery carrier. Microporous Mesoporous Mater. 229, 166\u2013177. https:\/\/doi.org\/10.1016\/j.micromeso.2016.04.029 (2016).","journal-title":"Microporous Mesoporous Mater."},{"key":"79983_CR62","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jcis.2020.01.110","volume":"567","author":"HDM Follmann","year":"2020","unstructured":"Follmann, H. D. M. et al. Nanofibrous silica microparticles\/polymer hybrid aerogels for sustained delivery of poorly water-soluble camptothecin. J. Colloid Interface Sci. 567, 92\u2013102. https:\/\/doi.org\/10.1016\/j.jcis.2020.01.110 (2020).","journal-title":"J. Colloid Interface Sci."},{"key":"79983_CR63","doi-asserted-by":"publisher","first-page":"26466","DOI":"10.18632\/oncotarget.25470","volume":"9","author":"K AbouAitah","year":"2018","unstructured":"AbouAitah, K. et al. Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action. Oncotarget 9, 26466\u201326490. https:\/\/doi.org\/10.18632\/oncotarget.25470 (2018).","journal-title":"Oncotarget"},{"key":"79983_CR64","doi-asserted-by":"publisher","first-page":"351","DOI":"10.4172\/2157-7439.1000351","volume":"7","author":"K AbouAitah","year":"2016","unstructured":"AbouAitah, K. et al. pH-controlled release system for curcumin based on functionalized dendritic mesoporous silica nanoparticles. J. Nanomed. Nanotechnol. 7, 351. https:\/\/doi.org\/10.4172\/2157-7439.1000351 (2016).","journal-title":"J. Nanomed. Nanotechnol."},{"key":"79983_CR65","doi-asserted-by":"publisher","first-page":"9652","DOI":"10.1002\/anie.201003451","volume":"49","author":"V Polshettiwar","year":"2010","unstructured":"Polshettiwar, V., Cha, D., Zhang, X. & Basset, J. M. High-surface-area silica nanospheres (KCC-1) with a fibrous morphology. Angew. Chem. Int. Ed. Engl. 49, 9652\u20139656. https:\/\/doi.org\/10.1002\/anie.201003451 (2010).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"79983_CR66","doi-asserted-by":"publisher","first-page":"109872","DOI":"10.1016\/j.micromeso.2019.109872","volume":"294","author":"CC Chong","year":"2020","unstructured":"Chong, C. C. et al. Facile synthesis of tunable dendritic fibrous SBA-15 (DFSBA-15) with radial wrinkle structure. Microporous Mesoporous Mater. 294, 109872. https:\/\/doi.org\/10.1016\/j.micromeso.2019.109872 (2020).","journal-title":"Microporous Mesoporous Mater."},{"key":"79983_CR67","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1038\/s41596-019-0177-z","volume":"14","author":"A Maity","year":"2019","unstructured":"Maity, A., Belgamwar, R. & Polshettiwar, V. Facile synthesis to tune size, textural properties and fiber density of dendritic fibrous nanosilica for applications in catalysis and CO2 capture. Nat. Protoc. 14, 2177\u20132204. https:\/\/doi.org\/10.1038\/s41596-019-0177-z (2019).","journal-title":"Nat. Protoc."},{"key":"79983_CR68","doi-asserted-by":"publisher","first-page":"9652","DOI":"10.1002\/anie.201003451","volume":"49","author":"V Polshettiwar","year":"2010","unstructured":"Polshettiwar, V., Cha, D., Zhang, X. & Basset, J. M. High-surface-area silica nanospheres (KCC-1) with a fibrous morphology. Angew. Chem. Int. Ed. 49, 9652\u20139656. https:\/\/doi.org\/10.1002\/anie.201003451 (2010).","journal-title":"Angew. Chem. Int. Ed."},{"key":"79983_CR69","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/cssc.201100379","volume":"5","author":"A Fihri","year":"2012","unstructured":"Fihri, A., Cha, D., Bouhrara, M., Almana, N. & Polshettiwar, V. Fibrous nano-silica (KCC-1)-supported palladium catalyst: Suzuki coupling reactions under sustainable conditions. Chemsuschem 5, 85\u201389. https:\/\/doi.org\/10.1002\/cssc.201100379 (2012).","journal-title":"Chemsuschem"},{"key":"79983_CR70","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1021\/cs300179q","volume":"2","author":"A Fihri","year":"2012","unstructured":"Fihri, A. et al. Fibrous nano-silica supported ruthenium (KCC-1\/Ru): A sustainable catalyst for the hydrogenolysis of alkanes with good catalytic activity and lifetime. ACS Catal. 2, 1425\u20131431. https:\/\/doi.org\/10.1021\/cs300179q (2012).","journal-title":"ACS Catal."},{"key":"79983_CR71","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1021\/acssuschemeng.5b00812","volume":"3","author":"M Dhiman","year":"2015","unstructured":"Dhiman, M., Chalke, B. & Polshettiwar, V. Efficient synthesis of monodisperse metal (Rh, Ru, Pd) nanoparticles supported on fibrous nanosilica (KCC-1) for catalysis. ACS Sustain. Chem. Eng. 3, 3224\u20133230. https:\/\/doi.org\/10.1021\/acssuschemeng.5b00812 (2015).","journal-title":"ACS Sustain. Chem. Eng."},{"key":"79983_CR72","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1002\/anie.201007254","volume":"50","author":"V Polshettiwar","year":"2011","unstructured":"Polshettiwar, V. et al. \u201cHydro-metathesis\u201d of olefins: A catalytic reaction using a bifunctional single-site tantalum hydride catalyst supported on fibrous silica (KCC-1) nanospheres. Angew. Chem. Int. Ed. 50, 2747\u20132751. https:\/\/doi.org\/10.1002\/anie.201007254 (2011).","journal-title":"Angew. Chem. Int. Ed."},{"key":"79983_CR73","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1021\/sc400126h","volume":"1","author":"M Bouhrara","year":"2013","unstructured":"Bouhrara, M. et al. Nitridated fibrous silica (KCC-1) as a sustainable solid base nanocatalyst. ACS Sustain. Chem. Eng. 1, 1192\u20131199. https:\/\/doi.org\/10.1021\/sc400126h (2013).","journal-title":"ACS Sustain. Chem. Eng."},{"key":"79983_CR74","doi-asserted-by":"publisher","first-page":"10886","DOI":"10.1021\/la501435a","volume":"30","author":"X Huang","year":"2014","unstructured":"Huang, X. et al. Dendritic silica nanomaterials (KCC-1) with fibrous pore structure possess high DNA adsorption capacity and effectively deliver genes in vitro. Langmuir 30, 10886\u201310898. https:\/\/doi.org\/10.1021\/la501435a (2014).","journal-title":"Langmuir"},{"key":"79983_CR75","doi-asserted-by":"publisher","first-page":"24783","DOI":"10.1039\/C9RA04845F","volume":"9","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Hu, K., He, J. & Zhang, Y. Improving the size uniformity of dendritic fibrous nano-silica by a facile one-pot rotating hydrothermal approach. RSC Adv. 9, 24783\u201324790. https:\/\/doi.org\/10.1039\/C9RA04845F (2019).","journal-title":"RSC Adv."},{"key":"79983_CR76","doi-asserted-by":"publisher","first-page":"5802","DOI":"10.1021\/acs.langmuir.6b00675","volume":"32","author":"E Febriyanti","year":"2016","unstructured":"Febriyanti, E. et al. Further insight into the definite morphology and formation mechanism of mesoporous silica KCC-1. Langmuir 32, 5802\u20135811. https:\/\/doi.org\/10.1021\/acs.langmuir.6b00675 (2016).","journal-title":"Langmuir"},{"key":"79983_CR77","doi-asserted-by":"publisher","first-page":"24888","DOI":"10.1038\/srep24888","volume":"6","author":"N Bayal","year":"2016","unstructured":"Bayal, N., Singh, B., Singh, R. & Polshettiwar, V. Size and fiber density controlled synthesis of fibrous nanosilica spheres (KCC-1). Sci. Rep. 6, 24888. https:\/\/doi.org\/10.1038\/srep24888 (2016).","journal-title":"Sci. Rep."},{"key":"79983_CR78","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijpharm.2016.04.047","volume":"506","author":"YC Hacene","year":"2016","unstructured":"Hacene, Y. C., Singh, A. & Van den Mooter, G. Drug loaded and ethylcellulose coated mesoporous silica for controlled drug release prepared using a pilot scale fluid bed system. Int. J. Pharmaceut. 506, 138\u2013147. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.04.047 (2016).","journal-title":"Int. J. Pharmaceut."},{"key":"79983_CR79","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.1039\/C4TB01030B","volume":"2","author":"SR Gayam","year":"2014","unstructured":"Gayam, S. R. & Wu, S.-P. Redox responsive Pd(ii) templated rotaxane nanovalve capped mesoporous silica nanoparticles: A folic acid mediated biocompatible cancer-targeted drug delivery system. J. Mater. Chem. B 2, 7009\u20137016. https:\/\/doi.org\/10.1039\/C4TB01030B (2014).","journal-title":"J. Mater. Chem. B"},{"key":"79983_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/polym11061059","author":"M Pishnamazi","year":"2019","unstructured":"Pishnamazi, M. et al. Design of controlled release system for paracetamol based on modified lignin. Polymers (Basel) https:\/\/doi.org\/10.3390\/polym11061059 (2019).","journal-title":"Polymers (Basel)"},{"key":"79983_CR81","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ijbiomac.2018.11.136","volume":"124","author":"M Pishnamazi","year":"2019","unstructured":"Pishnamazi, M., Iqbal, J., Shirazian, S., Walker, G. M. & Collins, M. N. Effect of lignin on the release rate of acetylsalicylic acid tablets. Int. J. Biol. Macromol. 124, 354\u2013359. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.11.136 (2019).","journal-title":"Int. J. Biol. Macromol."},{"key":"79983_CR82","volume-title":"The National Formulary, NF 18: Official from January 1, 1995","author":"The United States Pharmacopeia, USP 23","year":"1994","unstructured":"The United States Pharmacopeia, USP 23. The National Formulary, NF 18: Official from January 1, 1995 (UnitedStates Pharmacopeial Convention, North Bethesda, 1994)."},{"key":"79983_CR83","first-page":"33","volume":"57","author":"Y Ozkan","year":"2000","unstructured":"Ozkan, Y., Ozalp, Y., Savaser, A. & Ozkan, S. A. Comparative dissolution testing of paracetamol commercial tablet dosage forms. Acta Pol. Pharm. 57, 33\u201341 (2000).","journal-title":"Acta Pol. Pharm."},{"key":"79983_CR84","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1021\/cm0011559","volume":"13","author":"M Vallet-Regi","year":"2001","unstructured":"Vallet-Regi, M., R\u00e1mila, A., del Real, R. P. & P\u00e9rez-Pariente, J. A new property of MCM-41: Drug delivery system. Chem. Mater. 13, 308\u2013311. https:\/\/doi.org\/10.1021\/cm0011559 (2001).","journal-title":"Chem. Mater."},{"key":"79983_CR85","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.micromeso.2005.06.015","volume":"85","author":"Y Zhu","year":"2005","unstructured":"Zhu, Y. et al. Storage and release of ibuprofen drug molecules in hollow mesoporous silica spheres with modified pore surface. Microporous Mesoporous Mater. 85, 75\u201381. https:\/\/doi.org\/10.1016\/j.micromeso.2005.06.015 (2005).","journal-title":"Microporous Mesoporous Mater."},{"key":"79983_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jece.2020.104683","author":"R Soltani","year":"2020","unstructured":"Soltani, R. et al. Preparation of COOH-KCC-1\/polyamide 6 composite by in situ ring-opening polymerization: Synthesis, characterization, and Cd(II) adsorption study. J. Environ. Chem. Eng. https:\/\/doi.org\/10.1016\/j.jece.2020.104683 (2020).","journal-title":"J. Environ. Chem. Eng."},{"key":"79983_CR87","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/20550324.2019.1669925","volume":"5","author":"N Khantan","year":"2019","unstructured":"Khantan, N., Shadjou, N. & Hasanzadeh, M. Synthesize of dendritic fibrous nano-silica functionalized by cysteine and its application as advanced adsorbent. Nanocomposites 5, 104\u2013113. https:\/\/doi.org\/10.1080\/20550324.2019.1669925 (2019).","journal-title":"Nanocomposites"},{"key":"79983_CR88","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.eurpolymj.2019.07.043","volume":"119","author":"F Zarei","year":"2019","unstructured":"Zarei, F., Marjani, A. & Soltani, R. Novel and green nanocomposite-based adsorbents from functionalised mesoporous KCC-1 and chitosan-oleic acid for adsorption of Pb(II). Eur. Polym. J. 119, 400\u2013409. https:\/\/doi.org\/10.1016\/j.eurpolymj.2019.07.043 (2019).","journal-title":"Eur. Polym. J."},{"key":"79983_CR89","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.cej.2016.02.082","volume":"294","author":"H Hafizi","year":"2016","unstructured":"Hafizi, H., Chermahini, A. N., Saraji, M. & Mohammadnezhad, G. The catalytic conversion of fructose into 5-hydroxymethylfurfural over acid-functionalized KIT-6, an ordered mesoporous silica. Chem. Eng. J. 294, 380\u2013388. https:\/\/doi.org\/10.1016\/j.cej.2016.02.082 (2016).","journal-title":"Chem. Eng. J."},{"key":"79983_CR90","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.3390\/nano9101423","volume":"9","author":"KX Lee","year":"2019","unstructured":"Lee, K. X. et al. Bio-mediated synthesis and characterisation of silver nanocarrier, and its potent anticancer action. Nanomaterials 9, 1423 (2019).","journal-title":"Nanomaterials"},{"key":"79983_CR91","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jcis.2020.03.003","volume":"570","author":"R Soltani","year":"2020","unstructured":"Soltani, R., Marjani, A., Hosseini, M. & Shirazian, S. Meso-architectured siliceous hollow quasi-capsule. J. Colloid Interface Sci. 570, 390\u2013401. https:\/\/doi.org\/10.1016\/j.jcis.2020.03.003 (2020).","journal-title":"J. Colloid Interface Sci."},{"key":"79983_CR92","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijbiomac.2017.02.061","volume":"99","author":"P Treenate","year":"2017","unstructured":"Treenate, P. & Monvisade, P. In vitro drug release profiles of pH-sensitive hydroxyethylacryl chitosan\/sodium alginate hydrogels using paracetamol as a soluble model drug. Int. J. Biol. Macromol. 99, 71\u201378. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.02.061 (2017).","journal-title":"Int. J. Biol. Macromol."},{"key":"79983_CR93","unstructured":"PUBLIC ASSESSMENT REPORT of the Medicines Evaluation Board in the NetherlandsParacetamol Mylan 1000 mg, tablets Mylan B.V., The Netherlands. (2012)."},{"key":"79983_CR94","doi-asserted-by":"crossref","unstructured":"Kalantzi, L. Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Acetaminophen (Paracetamol). (2005).","DOI":"10.1002\/jps.20477"},{"key":"79983_CR95","unstructured":"European Medicines Agency, Paracetamol oral use, immediate release formulations product-specific bioequivalence guidance. (2017)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79983-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79983-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79983-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T01:50:55Z","timestamp":1670032255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79983-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["79983"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-79983-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"assertion":[{"value":"9 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"535"}}